CD274 and neoplasm: PTPR was used to restrict PD-L1 in tumor tissue by targeting TMUB1, and an αCTLA4 treatment was performed in the presence/absence of PTPR in EO771 tumor-bearing C57BL/6 mice (Fig. 7j).